-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
Our 12-month target price of $185 (down by $60) is 18.1x our FY 27 (Jun.) EPS view, vs. BR's three-year historical forward P/E average of 24.9x and the peer average of 16.2x. Our target multiple sits between its historical and peer averages as we balance the company's durable franchise against the increased uncertainty for future revenue conversion stemming from the lowered closed sales outlook. We keep our EPS estimates at $9.55 for FY 26 and $10.24 for FY 27. We believe BR exhibits strong operational fundamentals with 90%+ recurring revenue and robust market positioning, but faces near-term headwinds from lengthening sales cycles (closed sales guidance reduced 13%-17%) and material earnings volatility from $244M in digital asset gains that mask underlying performance. The company's strategic investments in tokenization, AI, and digitization position it well for long-term growth, though execution risk on complex platform deals and working capital management (accounts receivable up $254M) warrant monitoring.